Document › Details

Merck KGaA. (11/6/18). "Press Release: Merck Debuts at First China International Import Expo". Shanghai.

Region Region Shanghai
  Country China
Organisations Organisation Merck (DE) (Group)
  Organisation 2 China (govt)
Products Product China International Import Expo 2018 Shanghai
  Product 2 LIFE SCIENCES
Person Person Beckmann, Kai (Merck KGaA 201709– Executive Board Member for Performance Materisl before Human Resources)
     


> Merck makes impressive debut at the first China International Import Expo (CIIE) with a 300 m2 booth

> Merck is showcasing a wide spectrum of innovative products and technologies from its Healthcare, Life Science and Performance Materials business sectors


Today, Merck, a leading science and technology company, is making its debut at the first China International Import Expo (CIIE). The company is showcasing a wide spectrum of innovative products and technologies from its Healthcare, Life Science and Performance Materials business sectors at its 300 m2 booth. Merck is also hosting innovation workshops at CIIE to demonstrate its extensive experience across multiple industries and disciplines.

Kai Beckmann, Executive Board member of Merck and CEO Performance Materials, is participating in the CIIE on the first day, including the grand opening ceremony, Hongqiao Forum and other activities. Merck aims to leverage this unique platform to demonstrate its commitment to and confidence in the Chinese market as well as its continuous investments in China in recent years.

“Industry upgrades in China are happening in every sector we operate in. CIIE is not only a venue for companies to demonstrate products and technologies, but also a platform for us to collaborate with our partners to enhance the innovation and industry upgrades in China with our innovative technologies and solutions. It will enable Merck to become embedded in the local innovation ecosystem to shape future industry development with our partners,” said Kai Beckmann.

Holding the CIIE is a significant move for the Chinese government, giving firm support to trade liberalization and economic globalization. It also aims to actively open the Chinese market to the world, enabling countries and regions all over the world to strengthen economic cooperation and trade, and to promote global trade and world economic growth. The grand expo is attracting more than 2,000 government officials, international organization leaders, entrepreneurs, and scholars from over 130 countries and regions who will attend the opening ceremony and Hongqiao Forum. More than 3,000 companies from 130 countries and regions are exhibiting at the CIIE.


For more information, please contact Andreas Schwab
+49 6151 72-53758


All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.


About Merck

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2017, Merck generated sales of € 15.3 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.


About Merck in China

Merck has been in China for over 80 years. In 1933, Merck founded E. Merck Chemical Co., Ltd., its first subsidiary in Shanghai.

China is one of the most strategically important countries for Merck and has become a global center of innovation for Merck. Merck’s Healthcare in Nantong, Life Science in Nantong and Performance Materials in Shanghai have investments of 170 million Euros, 80 million Euros, and 44 million Euros respectively. Additionally, Merck hosts a global Healthcare R&D hub in Beijing, Performance Materials R&D centers, and Life Science labs in Shanghai.

Every day, Merck’s 3,200 committed employees in China are delivering high-quality, innovative products in healthcare, life science and performance materials which have a significant impact on people’s lives.

   
Record changed: 2019-08-04

Advertisement

[iito] Business Intelligence – The Elephants Are Coming 560x91px

More documents for Merck (DE) (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top